Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
2001

Consensus

You must be logged in to download this publication.

Select Book Type

Paperback - $40.50
Ebook - $33.29

See project
Request an exam or desk copy

In this report, the Immunization Safety Review committee examines the hypothesis of whether or not the use of vaccines containing the preservative thimerosal can cause neurodevelopmental disorders (NDDs), specifically autism, attention deficit/hyperactivity disorder (ADHD), and speech or language delay.

Additional materials

Press Release

Publication information

136 pages · 6 x 9 · paperback
ISBN Paperback: 0-309-07636-6
ISBN Ebook: 0-309-56573-1
DOI: https://doi.org/10.17226/10208

Suggested citation

Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press.

Import this citation to:

Bibtext
EndNote
Reference manager

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

Search this publication

Front Matter i-xiv
Executive Summary 1-18
Thimerosol-Containing Vaccines and Neurodevelopmental Disorders 19-19
Origins of the Immunization Safety Review Project 20-21
The Charge of the Committee 22-22
The Study Process The Framework for Assessing Causality 23-26
Under Review: Thimerosol Containing Vaccines and Neurodevelopmental Disorders 27-37
Plausibility Assessment 38-64
Causality Argument 65-65
Significance Assessment 66-74
Recommendations Regarding the Public Health Response 75-81
Summary 82-85
References 86-94
Appendix A 95-106
Appendix B 107-110
Appendix C 111-116
Appendix D 117-122

Log In

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Email (required)

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (2001)

Chapter: Thimerosol-Containing Vaccines and Neurodevelopmental Disorders

Additional materials

Publication information

Suggested citation

My Academies

Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (2001)

Chapter: Thimerosol-Containing Vaccines and Neurodevelopmental Disorders